81873920/National Natural Science Foundation of China[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Effectiveness of lenvatinib plus immune checkpoint inhibitors in primary advanced hepatocellular carcinoma beyond oligometastasis.

Wang XH, Liu CJ, Wen HQ, Duan XH, Jiao YQ, Liu YJ, Chen MS, Zhu KS, Mao XH, Zhou QF. Wang XH, et al. Clin Transl Med. 2023 Mar;13(3):e1214. doi: 10.1002/ctm2.1214. Clin Transl Med. 2023. PMID: 36855781 Free PMC article.

Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study.

Guo Y, Wu J, Liang L, Zhu K, Zhou J, Lin L, Chen Y, Cao B, He M, Lian H, Huang W, Cai M. Guo Y, et al. Cancer Imaging. 2023 Sep 25;23(1):91. doi: 10.1186/s40644-023-00604-4. Cancer Imaging. 2023. PMID: 37749616 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters